Arrayjet’s Post

If you are working on #cellandgenetherapies and using #AAV for delivery and working on #plasmidengineering I believe you will be interested in this webinar coming up next week on March 19, 2024. #AAV #celltherapy #cellandgenetherapy #LonzaCGT #RealizingPotentialTogether

Simplifying new discoveries with 3D cell models...

Introducing AgentV for 10x Exosome Yields - https://lnkd.in/gtBsBpfa AgentV-DSP is a downstream processing treatment that solves DSP filtration problems by breaking up biological components in conditioned media to prevent filter fouling and particle loss. Each bottle of this powerful reagent treats 5L of media and can increase your particle yield ten-fold. Made by RoosterBio Inc., a leader in cutting-edge exosome solutions, AgentV-DSP is a downstream processing treatment that solves DSP filtration problems by breaking up biological components in conditioned media to prevent filter fouling and particle loss. Each bottle of this powerful reagent treats 5L of media and can increase your particle yield ten-fold. AgentV-DSP is the easiest process solution on the market, allowing you to increase yields by adding 1mL per 1L of harvested media: - Up to ten times more EV yield during your DSP - Decreased filter fouling during the critical EV loss step - Chemically defined and supports large-volume treatment Learn more at: https://lnkd.in/gtBsBpfa #exosomes #extracellularvesicles #research Kim Hastings

Introducing AgentV for 10x Exosome Yields - https://lnkd.in/gtBsBpfa AgentV-DSP is a downstream processing treatment that solves DSP filtration problems by breaking up biological components in conditioned media to prevent filter fouling and particle loss. Each bottle of this powerful reagent treats 5L of media and can increase your particle yield ten-fold. Made by RoosterBio Inc., a leader in cutting-edge exosome solutions, AgentV-DSP is a downstream processing treatment that solves DSP filtration problems by breaking up biological components in conditioned media to prevent filter fouling and particle loss. Each bottle of this powerful reagent treats 5L of media and can increase your particle yield ten-fold. AgentV-DSP is the easiest process solution on the market, allowing you to increase yields by adding 1mL per 1L of harvested media: - Up to ten times more EV yield during your DSP - Decreased filter fouling during the critical EV loss step - Chemically defined and supports large-volume treatment Learn more at: https://lnkd.in/gtBsBpfa #exosomes #extracellularvesicles #research

An innovation in production scale cell disruption is COMING!! Get ready for a production scale solution that ensures consistent pressure across the batch cycle for maximizing protein yields and improved product quality in cell disruption. Microfluidics specializes in the development and production of equipment for cell disruption and is excited about this unique approach. Stay tuned to learn more about this NEW PRODUCTION SCALE SOLUTION. To learn more about cell disruption, go to: https://hubs.la/Q02fX-DS0 #celldisruption # celllyse #Microfluidics #productionscalecelldisruption #productionscalecelldisruptionsolution

Huge news for #celldisruption from Microfluidics International Corporation🎉 Microfluidizer® Processors offer simpler, faster and more efficient cell lysis than any other technique. Ideally suited to rupturing various cell types, the wide and controlled shear rate range they can apply to samples minimises excess energy introduction, avoiding denaturation of delicate proteins. COMING SOON - an all new production scale Microfluidizer® specifically designed for cell disruption applications. Stay tuned for updates!

The benefits of manufacturing LVV with iVexSol’s stable cells involve not just scale, but also cost. We can enable about 540 more patients to be treated per 50L batch, with an estimated 80 percent reduction in both direct and indirect lentiviral vector production costs. These remarkable achievements are industry firsts. Please reach out to learn more about iVexSol’s scalable, industrialized Intelligent Manufacturing platform for LVV >> info@ivexsol.com #celltherapy #genetherapy #advancedtherapies #CGT #CAR-T #LVV #viralvector #lentiviralvector #iVexSol

Disrupt the status quo for cell disruption. Direct physical disruption methods, such as high-pressure homogenization, ball mill grinding, and cell wall rupture induced by freeze/thaw cycles in a cell paste, are widely employed in large-scale cell disruption operations. Microfluidics International Corporation will be launching a new commercial scale up instrument for cell disruption. Stay tuned for more updates. To learn more about effficient cell disruption click on our application notes page. https://lnkd.in/gE6kwrz5 #cellbiology #microbial #fermentation

Iris Kinetics technology empowers scientists to explore complex binding interactions with precision, speed, and label-free convenience. Leveraging the power of #microarrays, in a single experiment (lasting less than an hour), researchers can characterize the binding affinities of small or large biomolecules to multiple probes. The technology is transparent to DMSO, resulting in clean binding data for small molecule drug candidates investigations. This approach is most powerful when a profile of binding affinities is needed. Visit us in Philly at #BPS2024 #axiVEND booth 709, you’re in for an exciting glimpse into the future for diagnostic applications! #m2automation #drugdiscovery 

Accurate and efficient #CellSorting and dispensing with on-chip electrodes and micron-sized outlet channels. Read about Enplas's cell sorting and #Microfluidic development in our brochure: https://bit.ly/4a5255W #microfluidics #biotechnology #medicaldevice #ivd #diagnostics